Search
Rheumatoid Arthritis Paid Clinical Trials in Oregon
A listing of 6 Rheumatoid Arthritis clinical trials in Oregon actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 6 of 6
The state of Oregon currently has 6 active clinical trials seeking participants for Rheumatoid Arthritis research studies. These trials are conducted in various cities, including Portland, Eugene, Medford and Clackamas.
Featured Trial
Assessing an Investigational Medication on Major Adverse Cardiovascular Events Such as Heart Attack and Stroke
Recruiting
The main purpose of this study is to evaluate the cardiovascular safety of the investigational medication compared with a placebo in participants who are at an increased risk of adverse cardiovascular outcomes (ie. heart attack and stroke). Participants will be randomly assigned to receive either the investigational medication or a placebo, with safety and tolerability being monitored throughout. Should you express interest, you will be contacted directly by the research site, who will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.
Conditions:
Ischemic heart disease (IHD)
Overweight
Metabolic syndrome
Diabetes related diseases
Cardiovascular Disease
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Studying an Investigational Vaccine for a Common Herpesvirus in Adolescents
Recruiting
This study aims to evaluate the safety, effectiveness, and immune response of an investigational vaccine targeting cytomegalovirus (CMV), a common type of herpesvirus. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. The study will monitor participants’ health and immune response over an 18-month period. Should you express interest for the adolescent in your care, you will be contacted directly by the research site. They will provide further details and address any questions you may have about study requirements, risks/benefits, and any compensation.
Conditions:
Preventative Trials
Healthy
All Conditions
Parent / Carer of child aged 0-17
Featured Trial
Investigational Combined COVID-19 and Influenza Vaccine
Recruiting
This study aims to evaluate the safety, immune response, and tolerability of an investigational vaccine designed to protect against both COVID-19 and seasonal influenza in adults aged 18 to 64 years. Participants will be randomly assigned to receive the investigational vaccine or a currently available vaccine. The study involves a single vaccination followed by monitoring over several months. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.
Conditions:
Interested in vaccine studies
All Conditions
Healthy
Preventative Trials
Featured Trial
Investigational Stomach Flu Vaccine
Recruiting
The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.
Conditions:
Interested in vaccine studies
All Conditions
Preventative Trials
Healthy
Age 60+
Featured Trial
Healthy Volunteer Oral COVID-19 Preventative Drug
Recruiting
The main objectives of this study are to assess the safety, effectiveness, and immune response of an investigational oral preventative drug (oral vaccination) in preventing COVID-19 and its symptoms. Participants will be randomly assigned to receive the investigational oral vaccine or a currently available market COVID-19 vaccine. Should you express interest, you will be contacted directly by the research site, who will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.
Conditions:
Preventative Trials
Healthy
All Conditions
Interested in vaccine studies
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Recruiting
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/20/2025
Locations: Good Samaritan Hospital Corvallis, Corvallis, Oregon
Conditions: Rheumatoid Arthritis
RA-PRO PRAGMATIC TRIAL
Recruiting
The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (tsDMARD; choose among existing medications, currently, tofacitinib, baricitinib, upadacitinib) in patients with active RA despite the use of a TNFi-biologic. In practice, most patients receive another... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/01/2024
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Rheumatoid Arthritis
G7 Acetabular System with Vivacit-E or Longevity Liner PMCF Study
Recruiting
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/22/2024
Locations: Slocum Center for Orthopedics & Sports Medicine, Eugene, Oregon +1 locations
Conditions: Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip
Rheumatoid Arthritis Shared Decision Making
Recruiting
Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of Veterans with RA. The purpose of this project is to evaluate the effectiveness of a multi-component shared decision making intervention on RA disease activity, adherence to RA medications and patient... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: VA Portland Health Care System, Portland, OR, Portland, Oregon
Conditions: Rheumatoid Arthritis
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
Recruiting
Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/19/2024
Locations: Kaiser Permanente Northwest Center for Health Research, Portland, Oregon
Conditions: Osteoarthritis Shoulder, Avascular Necrosis of the Head of Humerus, Rheumatoid Arthritis Shoulder
ConsideRAte Study - Splenic Stimulation for RA
Recruiting
This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized Control Trial period (Period 1), an Open Label period (Period 2), a Treat-to-target period (Period 3), and a Long-term Follow-up period (Period 4). Participants eligible for implant will have active r... Read More
Gender:
All
Ages:
Between 22 years and 75 years
Trial Updated:
05/20/2024
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Rheumatoid Arthritis
1 - 6 of 6